PR Newswire BiotechOriginal article
Gan & Lee and Menarini Group Partner to Advance Bofanglutide in Europe
PartnershipBofanglutidePositive
AI Analysis
Summary
Gan & Lee Pharmaceuticals entered into an exclusive license agreement with The Menarini Group to advance Bofanglutide in Europe, expanding the drug's geographic footprint through a multinational partnership.
Importance:6/10
Sentiment:
0.60
partnershiplicensingEuropeGan & LeeMenarini
Related Companies
Read the original article
Published by PR Newswire Biotech on September 3, 2026 9:37 AM
